SEATTLE, Nov. 17, 2014 /PRNewswire/ -- CTI BioPharma Corp. (CTI) (NASDAQ and MTA: CTIC) announced today management will present at the following upcoming investor conferences.
Jefferies 2014 Global Healthcare Conference
Wednesday, November 19 at 9:20 a.m. GMT / 4:20 a.m. EST, London, England.
Piper Jaffray 26th Annual Healthcare Conference
Wednesday, December 3 at 9:00 a.m. EST, New York, NY.
The presentation will also be webcast live and available for replay after the presentation. The webcast can be accessed at www.ctibiopharma.com.
About CTI BioPharma
CTI BioPharma Corp. (NASDAQ and MTA: CTIC) is a biopharmaceutical company focused on the acquisition, development and commercialization of novel targeted therapies covering a spectrum of blood-related cancers that offer a unique benefit to patients and healthcare providers. CTI has a commercial presence in Europe and a late-stage development pipeline, including pacritinib, CTI's lead product candidate that is currently being studied in a Phase 3 program for the treatment of patients with myelofibrosis. CTI is headquartered in Seattle, Washington, with offices in London and Milan under the name CTI Life Sciences Limited. For additional information and to sign up for email alerts and get RSS feeds, please visit www.ctibiopharma.com.
Contacts:
Monique Greer
+1 206-272-4343
mgreer@ctibiopharma.com
Ed Bell
+1 206-282-7100
ebell@ctibiopharma.com
In Europe: CTI Life Sciences Limited, Milan Branch
Laura Villa
+39 02 94751572
lvilla@cti-lifesciences.com
SOURCE CTI BioPharma Corp.
